Agriculture and Forestry, Art, Design and Architecture, Business and Management, Economics and Econometrics, Education, Engineering and Technology, History, Philosophy, Theology, Law, Medicine and Health Sciences, Natural Sciences and Social Sciences and their 256 sub-branches can analyse the world, countries and regions. You can also analyse them according to i10 index and citation numbers. *Jul 17, 2024 According to Total H Index. BETA VERSION. Subject field ranking in world, region, country and university is beta version since subject field 'others' (652.491) scientists profile whose branch cannot be determined, not yet edited or determined) is excluded, so the ranking will change as the others fields are edited. Please note that. See also: University Subject Rankings
AD Scientific Index - Subject Rankings - 2024 | H INDEX | i10 INDEX | CITATION | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
University / Institution |
Country | Region | World | Name | Country | University / Institution | Subject | Total | Last 6 year | Last 6 year/total | Total | Last 6 year | Last 6 year/total | Total | Last 6 year | Last 6 year/total |
1 | 143 | 156 | 348 |
|
United States | National Cancer Institute |
Others
|
216 | 101 | 0.468 | 1,445 | 897 | 0.621 | 192,635 | 49,465 | 0.257 |
2 | 291 | 316 | 772 |
|
United States | National Cancer Institute |
Others
kidney cancer | VHL | fumarate hydratase | FLCN | MET | |
186 | 91 | 0.489 | 673 | 441 | 0.655 | 138,947 | 53,890 | 0.388 |
3 | 579 | 625 | 1,383 |
|
United States | National Cancer Institute |
Others
Cancer | |
157 | 103 | 0.656 | 481 | 400 | 0.832 | 113,171 | 54,262 | 0.479 |
4 | 613 | 660 | 1,439 |
|
United States | National Cancer Institute |
Others
HPV epidemiology | |
156 | 77 | 0.494 | 547 | 379 | 0.693 | 100,787 | 32,086 | 0.318 |
6 | 1,551 | 1,666 | 3,375 |
|
United States | National Cancer Institute |
Others
cancer epidemiology | low-dose protracted occupational radiation | radiofrequency radiation and mobile telephone use | residential | |
127 | 67 | 0.528 | 431 | 296 | 0.687 | 116,979 | 47,539 | 0.406 |
8 | 1,864 | 2,005 | 4,001 |
|
United States | National Cancer Institute |
Others
cancer | occupation | |
122 | 59 | 0.484 | 460 | 274 | 0.596 | 50,471 | 13,341 | 0.264 |
9 | 1,924 | 2,076 | 4,140 |
|
United States | National Cancer Institute |
Others
Tumor microenvironment | extracellular matrix | |
121 | 34 | 0.281 | 272 | 118 | 0.434 | 55,411 | 5,159 | 0.093 |
10 | 2,047 | 2,208 | 4,390 |
|
United States | National Cancer Institute |
Others
chemical biology | |
119 | 60 | 0.504 | 302 | 197 | 0.652 | 53,291 | 13,320 | 0.250 |
11 | 2,175 | 2,342 | 4,673 |
|
United States | National Cancer Institute |
Others
Behavioral and psychosocial oncology | patient-reported outcomes research | |
117 | 65 | 0.556 | 391 | 285 | 0.729 | 47,348 | 16,685 | 0.352 |
13 | 2,648 | 2,856 | 5,703 |
|
United States | National Cancer Institute |
Others
cancer | HIV | organ transplantation | |
111 | 71 | 0.640 | 336 | 275 | 0.818 | 48,435 | 19,035 | 0.393 |
Click for INSTITUTIONAL BULK REGISTRATION and PREMIUM MEMBERSHIP advantages |
||||||||||||||||
14 | 2,960 | 3,199 | 6,356 |
|
United States | National Cancer Institute |
Others
|
108 | 65 | 0.602 | 223 | 172 | 0.771 | 52,852 | 14,808 | 0.280 |
15 | 4,187 | 4,557 | 9,119 |
|
United States | National Cancer Institute |
Others
|
98 | 78 | 0.796 | 335 | 323 | 0.964 | 39,664 | 24,096 | 0.608 |
16 | 5,112 | 5,583 | 11,264 |
|
United States | National Cancer Institute |
Others
pancreatic cancer | |
93 | 54 | 0.581 | 210 | 186 | 0.886 | 25,214 | 10,631 | 0.422 |
18 | 6,155 | 6,723 | 13,578 |
|
United States | National Cancer Institute |
Others
Cancer | Aging | Cell Cycle | Drug Discovery | |
88 | 61 | 0.693 | 175 | 138 | 0.789 | 49,148 | 22,827 | 0.464 |
19 | 6,228 | 6,804 | 13,763 |
|
United States | National Cancer Institute |
Others
Leukemia | Lymphoma | Flow Cytometry | |
88 | 50 | 0.568 | 251 | 155 | 0.618 | 37,809 | 15,974 | 0.422 |
20 | 6,357 | 6,943 | 14,067 |
|
United States | National Cancer Institute |
Others
liver | cancer | immunology | immunotherapy | |
87 | 67 | 0.770 | 229 | 178 | 0.777 | 56,120 | 30,395 | 0.542 |
21 | 6,972 | 7,617 | 15,578 |
|
United States | National Cancer Institute |
Others
longitudinal data analysis | biomarker analyses | chemical mixtures | epidemiologic methods | cancer research | |
85 | 47 | 0.553 | 293 | 193 | 0.659 | 31,323 | 9,133 | 0.292 |
23 | 8,170 | 8,941 | 18,413 |
|
United States | National Cancer Institute |
Others
Population-based surveillance | |
81 | 49 | 0.605 | 158 | 124 | 0.785 | 104,165 | 42,801 | 0.411 |
26 | 9,912 | 10,892 | 22,777 |
|
United States | National Cancer Institute |
Others
cancer | vaccine | radiation | chemotherapy | |
76 | 47 | 0.618 | 167 | 117 | 0.701 | 19,341 | 8,517 | 0.440 |
29 | 11,759 | 12,950 | 27,419 |
|
United States | National Cancer Institute |
Others
|
72 | 39 | 0.542 | 217 | 129 | 0.594 | 21,071 | 5,851 | 0.278 |
2 | 143 | 10,411 | 30,303 |
|
Norway | National Institute of Occupational Health, Norway |
Others
Cancer | lung cancer | genetic susceptibility | carcinogenesis | toxicology | |
70 | 31 | 0.443 | 169 | 75 | 0.444 | 17,802 | 3,502 | 0.197 |
31 | 13,347 | 14,768 | 31,622 |
|
United States | National Cancer Institute |
Others
growth factor signaling | receptor tyrosine kinases | cancer research | |
69 | 32 | 0.464 | 145 | 75 | 0.517 | 23,151 | 5,507 | 0.238 |
32 | 13,571 | 15,018 | 32,235 |
|
United States | National Cancer Institute |
Others
Cancer Diagnosis and Treatment | |
68 | 47 | 0.691 | 127 | 88 | 0.693 | 22,913 | 13,312 | 0.581 |
33 | 13,694 | 15,154 | 32,571 |
|
United States | National Cancer Institute |
Others
Computational structure biology | |
68 | 41 | 0.603 | 147 | 114 | 0.776 | 19,030 | 5,924 | 0.311 |
34 | 13,951 | 15,439 | 33,139 |
|
United States | National Cancer Institute |
Others
lung cancer growth factors | |
68 | 22 | 0.324 | 250 | 63 | 0.252 | 19,427 | 2,344 | 0.121 |